Polypeptide Laboratories
Trending Articles
Related Content
Manufacturing
Biotech chooses PolyPeptide Group for vaccine adjuvant intermediates
PolyPeptide Group has announced it will produce two key intermediates used in the production of Matrix-M, the adjuvant component of the vaccine used to enhance immune response and stimulate high levels of neutralising antibodies
Ingredients
Peptide producer NeoMPS expands facilities in France
<p>Peptide specialist NeoMPS, based in Strasbourg, France has started construction of a new 2400m<s type="sup">2</s> facility that will double the company's cGMP production capacity for late stage development and commercial scale peptide manufacturing.</p>